Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

The 2007 revised ESC/ESH Guidelines in the management of hypertension: clarifying individual patient care

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kakar P, Lip GY . Towards improving the clinical assessment and management of human hypertension: an overview from this Journal. J Hum Hypertens 2006; 20: 913–916.

    Article  CAS  Google Scholar 

  2. Lip GY, Barnett AH, Bradbury A, Cappuccio FP, Gill PS, Hughes E et al. Ethnicity and cardiovascular disease prevention in the United Kingdom: a practical approach to management. J Hum Hypertens 2007; 21: 183–211.

    Article  CAS  Google Scholar 

  3. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28: 1462–1536.

    PubMed  Google Scholar 

  4. Gosse P, MacFadyen RJ . Does eplerenone have a future in the management of hypertension in Europe? J Hum Hypertens 2006; 20: 829–832.

    Article  CAS  Google Scholar 

  5. Strasser RH, Puig JG, Farsang C, Croket M, Li J, van Ingen H . A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. J Hum Hypertens 2007, [E-pub ahead of print: 31 May 2007; doi:10.1038/sj.jhh.1002220].

  6. Patel A, Chalmers J, Poulter N . ADVANCE: action in diabetes and vascular disease. J Hum Hypertens 2005; 19(Suppl 1): S27–S32.

    Article  CAS  Google Scholar 

  7. Varughese GI, Patel JV, Lip GY . Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement? J Hum Hypertens 2006; 20: 635–637.

    Article  CAS  Google Scholar 

  8. Czupryniak L, Saryusz-Wolska M, Pawlowski M, Loba J . Elevated systolic blood pressure is present in almost all individuals with newly diagnosed diabetes. J Hum Hypertens 2006; 20: 231–233.

    Article  CAS  Google Scholar 

  9. Karalliedde J, Viberti G . Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes. J Hum Hypertens 2006; 20: 239–253.

    Article  CAS  Google Scholar 

  10. Varughese GI, Lip GY . Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation. J Hum Hypertens 2005; 19: 421–424.

    Article  CAS  Google Scholar 

  11. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, et al., Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34: 1699–1703.

    Article  Google Scholar 

  12. Borlongan CV, Hess DC . Stroke, with or with no ice? Observations on amphetamine for the management of acute stroke. J Hum Hypertens 2007; 21: 594–597.

    Article  CAS  Google Scholar 

  13. Chrysant SG . Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence. J Hum Hypertens 2005; 19: 923–931.

    Article  CAS  Google Scholar 

  14. Watson T, Lip GY . Blood pressure measurement in atrial fibrillation: goodbye mercury? J Hum Hypertens 2006; 20: 638–640.

    Article  CAS  Google Scholar 

  15. Jani B, Bulpitt CJ, Rajkumar C . Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting. J Hum Hypertens 2006; 20: 543–545.

    Article  CAS  Google Scholar 

  16. Boos CJ, Lip GY . Targeting the renin-angiotensin-aldosterone system in atrial fibrillation: from pathophysiology to clinical trials. J Hum Hypertens 2005; 19: 855–859.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R J MacFadyen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacFadyen, R. The 2007 revised ESC/ESH Guidelines in the management of hypertension: clarifying individual patient care. J Hum Hypertens 21, 757–761 (2007). https://doi.org/10.1038/sj.jhh.1002266

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002266

This article is cited by

Search

Quick links